Home > News > Pharmaceutical News

Glenmark gets approval for Rizatriptan Benzoate tablet

Posted on Jan 02, 04:55PM | UNI

Pharma major, Glenmark today said its US subsidiary Glenmark Generics Inc, has got approval from the United States Food and Drug Administration (USFDA) for Rizatriptan Benzoate tablets, its generic version of Merck's Maxalt tablets.

The tablet is used to treat migraine headaches.

The approval is for the 5 mg and 10 mg of Rizatriptan, a company release said According to IMS Health for the 12 month period ending September 2012, Rizatriptan Benzote tablets achieved sales of USD 333 million,a release said.